2023 Regular Session • Texas Legislature
SB773
Legislative Summary
Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.
Demographic Impact
Overall analysis of equity impact
70% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
2/7/2023
Received by the Secretary of the Senate
Senate
2/7/2023
Filed
Senate
3/1/2023
Read first time
Senate
3/1/2023
Referred to Health & Human Services
Senate
3/29/2023
Scheduled for public hearing on . . .
Senate
3/29/2023
Considered in public hearing
Senate
3/29/2023
Testimony taken in committee
Senate
3/29/2023
Left pending in committee
Senate
4/17/2023
Considered in public hearing
Senate
4/17/2023
Vote taken in committee
Senate
4/19/2023
Reported favorably as substituted
Senate
4/19/2023
Recommended for local & uncontested calendar
Senate
4/19/2023
Committee report printed and distributed
Senate
4/27/2023
Placed on local & uncontested calendar
Senate
4/27/2023
Placed on intent calendar
Senate
4/27/2023
Laid before the Senate
Senate
4/27/2023
Read 2nd time & passed to engrossment
Senate
4/27/2023
Vote recorded in Journal
Senate
4/27/2023
Three day rule suspended
Senate
4/27/2023
Record vote
Senate
4/27/2023
Read 3rd time
Senate
4/27/2023
Passed
Senate
4/27/2023
Record vote
Senate
4/27/2023
Reported engrossed
Senate
4/27/2023
Received from the Senate
House of Representatives
5/4/2023
Read first time
House of Representatives
5/4/2023
Referred to Public Health
House of Representatives
5/8/2023
Considered in public hearing
House of Representatives
5/8/2023
Reported favorably w/o amendment(s)
House of Representatives
5/9/2023
Comte report filed with Committee Coordinator
House of Representatives
5/9/2023
Committee report distributed
House of Representatives
5/10/2023
Committee report sent to Calendars
House of Representatives
5/11/2023
Laid out in lieu of companion HB 638
House of Representatives
5/11/2023
Read 2nd time
House of Representatives
5/11/2023
Amended 1-Toth
House of Representatives
5/11/2023
Amendment(s) offered 2-Toth
House of Representatives
5/11/2023
Point of order withdrawn (amendment) Rule 11, Section 2
House of Representatives
5/11/2023
Amendment withdrawn 2-Toth
House of Representatives
5/11/2023
Passed to 3rd reading as amended
House of Representatives
5/12/2023
Read 3rd time
House of Representatives
5/12/2023
Passed
House of Representatives
5/12/2023
Record vote RV#1665
House of Representatives
5/12/2023
Statement(s) of vote recorded in Journal
House of Representatives
5/12/2023
House passage as amended reported
Senate
5/16/2023
House amendment(s) laid before the Senate
Senate
5/16/2023
Read
Senate
5/16/2023
Senate refuses to concur
Senate
5/16/2023
Senate requests conference committee
Senate
5/16/2023
Senate appoints conferees
Senate
5/17/2023
Senate refuses to concur-reported
House of Representatives
5/17/2023
Senate requests conference committee-reported
House of Representatives
5/17/2023
Senate appoints conferees-reported
House of Representatives
5/19/2023
House grants request for conference committee
House of Representatives
5/19/2023
House appoints conferees
House of Representatives
5/19/2023
House grants request for conf comm-reported
Senate
5/19/2023
House appoints conferees-reported
Senate
5/23/2023
Conference committee report filed
Senate
5/24/2023
Conf. Comm. Report distributed
House of Representatives
5/25/2023
House adopts conference committee report
House of Representatives
5/25/2023
Record vote RV#2137
House of Representatives
5/25/2023
Statement(s) of vote recorded in Journal
House of Representatives
5/25/2023
House adopts conf. comm. report-reported
Senate
5/26/2023
Senate adopts conference committee report
Senate
5/26/2023
Record vote
Senate
5/26/2023
Senate adopts conf. comm. report-reported
House of Representatives
5/27/2023
Reported enrolled
Senate
5/28/2023
Signed in the Senate
Senate
5/29/2023
Signed in the House
House of Representatives
5/29/2023
Sent to the Governor
6/18/2023
Signed by the Governor
6/18/2023
Effective immediately
Amendments
House Amendment (H 2) 1-Toth
House Amendment (H 2) 1-Toth
5/11/2023Adopted
House Amendment (H 2) 2-Toth
House Amendment (H 2) 2-Toth
5/11/2023Not Adopted
Roll Call Votes
Senate adopts conference committee report
5/26/2023
31
Yea
0
Nay
0
Not Voting
0
Absent
Result: PASSED
Senate adopts conference committee report
5/26/2023
31
Yea
0
Nay
0
Not Voting
0
Absent
Result: PASSED
House adopts conference committee report RV#2137
5/25/2023
141
Yea
1
Nay
2
Not Voting
5
Absent
Result: PASSED
Read 3rd time RV#1665
5/12/2023
135
Yea
5
Nay
2
Not Voting
7
Absent
Result: PASSED
Three day rule suspended
4/27/2023
31
Yea
0
Nay
0
Not Voting
0
Absent
Result: PASSED
Read 3rd time
4/27/2023
31
Yea
0
Nay
0
Not Voting
0
Absent
Result: PASSED
Status Information
Current Status
Passed(6/18/2023)
Chamber
House of Representatives
Sine DiePrior Session
Sponsors
Republican: 5
Primary Sponsor
Tan Parker
Republican